Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Atomo Diagnostics Ltd. ( (AU:AT1) ) has shared an announcement.
Atomo Diagnostics Ltd. has announced its Annual General Meeting (AGM) scheduled for October 31, 2025, at its headquarters in Leichhardt, NSW. The company is adapting to recent legislative changes by providing AGM materials electronically, encouraging shareholders to access documents online and submit proxies in advance, reflecting a shift towards more efficient and environmentally friendly communication practices.
More about Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd. operates in the medical diagnostics industry, focusing on the development and commercialization of innovative rapid diagnostic test devices. The company is known for its user-friendly, integrated testing solutions that cater to various healthcare needs.
Average Trading Volume: 2,106,090
Technical Sentiment Signal: Buy
Current Market Cap: A$21.06M
For detailed information about AT1 stock, go to TipRanks’ Stock Analysis page.